Please see below for a list of search results.
The Human Tissue Authority (HTA) is aware that CryoSave AG has entered liquidation. PBKM FamiCord has taken over responsibility for the storage of CryoSave samples.
Clients of CryoSave can contact PBKM FamiCord directly for further advice.
Last week we completed our office move from Buckingham Palace Road to a brand-new office space in Stratford, East London.
We are delighted to announce the appointment of two new Board Members, Deborah Bowman and Jan Williams OBE.
Today the Human Tissue Authority (HTA) has published licence fee levels for the 2021/22 business year.We have not made any changes to licence fees for 2021/22 and we have replicated the same fees structure as last year. We have done this:
The HTA has published its three-year Strategy 2020-23 and annual Business Plan for 2020/21. The Strategy sets out a longer-term view of organisational priorities and activities that will support the ongoing delivery and development of effective regulation.
The HTA Portal is temporarily offline due to maintenance and essential upgrade work, but will be back up and running by Monday 2 November.
You will NOT be able to submit incident reports as usual until the Portal is back online.
If your case is urgent please see below for contact...
Congratulations to our Chair, Lynne Berry, who we are delighted to share has been awarded a CBE.
Following on from our announcement earlier this year on the postponement of our inspection activity, we can now confirm that there will be no scheduled site visit inspections this business year.
Every year, the HTA holds a public Authority meeting. This meeting is an opportunity for members of the public to attend and ask our Authority Members (the HTA Board) and the HTA’s Senior Management Team questions about our work in person.
Ministers are seeking to make up to five appointments to the board of the Human Tissue Authority (HTA).
As a Member of the Human Tissue Authority (HTA) you will: